DNA microarray-based gene expression profiling of estrogenic chemicals

Cellular and Molecular Life Sciences

Volumn 71, Issue 11, 2014, Pages 2065-2082

  Kiyama, Ryoiti ^a   Zhu, Yun ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

DNA microarray; Estrogen; Focused microarray; Gene expression profiling; Phytoestrogen; Signal transduction

Indexed keywords

BRCA1 PROTEIN; COMPLEMENTARY DNA; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; PHYTOESTROGEN;

CELL PROLIFERATION; DEGRADATION KINETICS; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC VARIABILITY; HORMONE ACTION; HORMONE DETERMINATION; HORMONE METABOLISM; HUMAN; NONHUMAN; PHYTOCHEMISTRY; REVIEW; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; ENDOCRINE DISRUPTORS; ESTROGENS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MICROARRAY ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHYTOCHEMICALS; PHYTOESTROGENS; QUALITY CONTROL; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 84901647377     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1544-5     Document Type: Review

References (173)

1. Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270(5235):467-470
2. Churchill GA (2002) Fundamentals of experimental design for cDNA microarrays. Nat Genet 32(Suppl):490-495
3. Leung YF, Cavalieri D (2003) Fundamentals of cDNA microarray data analysis. Trends Genet 19(11):649-659
4. Reis-Filho JS, Pusztai L (2011) Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet 378(9805):1812-1823
5. Inoue A, Tanji M, Kiyama R (2006) Focused microarray analysis: characterization of phenomes by gene expression profiling. Curr Pharmacogenomics 4:245-260
6. Glas AM, Floore A, Delahaye LJ, Witteveen AT, Pover RC, Bakx N, Lahti-Domenici JS, Bruinsma TJ, Warmoes MO, Bernards R, Wessels LF, Van't Veer LJ (2006) Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 7:278
7. Monzon FA, Dumur CI (2010) Diagnosis of uncertain primary tumors with the Pathwork tissue-of-origin test. Expert Rev Mol Diagn 10(1):17-25
8. European Community. (2006) Regulation (EC) No. 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). EC Regulation, retrieved from http://ec.europa.eu/environment/chemicals/reach/reach-intro.htm
9. National Research Council (2007) Toxicity Testing in the 21st Century: A vision and a strategy. National Academies Press, Washington
10. Mueller SO (2004) Xenoestrogens: mechanisms of action and detection methods. Anal Bioanal Chem 378(3):582-587
11. Tanji M, Kiyama R (2004) Expression profiling of estrogen responsive genes using genomic and proteomic techniques for the evaluation of endocrine disruptors. Curr Pharmacogenomics 2:255-266
12. Moggs JG (2005) Molecular responses to xenoestrogens: mechanistic insights from toxicogenomics. Toxicology 213(3):177-193
13. Nagai MA, Brentani MM (2008) Gene expression profiles in breast cancer to identify estrogen receptor target genes. Mini Rev Med Chem 8(5):448-454
14. Hah N, Kraus WL (2014) Hormone-regulated transcriptomes: lessons learned from estrogen signaling pathways in breast cancer cells. Mol Cell Endocrinol 382(1):652-664
15. Roy NC, Altermann E, Park ZA, McNabb WC (2011) A comparison of analog and Next-Generation transcriptomic tools for mammalian studies. Brief Funct Genomics 10(3):135-150
16. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Ström A, Treuter E, Warner M, Gustafsson JA (2007) Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87(3):905-931
17. Ibrahim NK, Hortobagyi GN (1999) The evolving role of specific estrogen receptor modulators (SERMs). Surg Oncol 8(2):103-123
18. Herrero M, Ibáñiez E, Cifuentes A (2005) Analysis of natural antioxidants by capillary electromigration methods. J Sep Sci 28(9-10):883-897
19. Meulenberg EP (2009) Phenolics: occurrence and immunochemical detection in environment and food. Molecules 14(1):439-473
20. Gajecki M (2002) Zearalenone - undesirable substances in feed. Pol J Vet Sci 5(2):117-122
21. Bennett JW, Klich M (2003) Mycotoxins. Clin Microbiol Rev 16(3):497-516
22. Cornwell T, Cohick W, Raskin I (2004) Dietary phytoestrogens and health. Phytochemistry 65(8):995-1016
23. Chakraborty S, Chakraborty TR (2009) Estrogen-like endocrine disrupting chemicals affecting puberty in humans-a review. Med Sci Monit 15(6):RA137-RA145
24. Frye CA, Bo E, Calamandrei G, Calzà L, Dessì-Fulgheri F, Fernández M, Fusani L, Kah O, Kajta M, Le Page Y, Patisaul HB, Venerosi A, Wojtowicz AK, Panzica GC (2012) Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behaviour and neuroendocrine systems. J Neuroendocrinol 24(1):144-159
25. Jefferson WN, Padilla-Banks E, Clark G, Newbold RR (2002) Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. J Chromatogr B Analyt Technol Biomed Life Sci 777(1-2):179-189
26. Serafim TL, Carvalho FS, Marques MP, Calheiros R, Silva T, Garrido J, Milhazes N, Borges F, Roleira F, Silva ET, Holy J, Oliveira PJ (2011) Lipophilic caffeic and ferulic acid derivatives presenting cytotoxicity against human breast cancer cells. Chem Res Toxicol 24(5):763-774
27. Ng TB, Ye XJ, Wong JH, Fang EF, Chan YS, Pan W, Ye XY, Sze SC, Zhang KY, Liu F, Wang HX (2011) Glyceollin, a soybean phytoalexin with medicinal properties. Appl Microbiol Biotechnol 90(1):59-68
28. Johnson JJ, Syed DN, Suh Y, Heren CR, Saleem M, Siddiqui IA, Mukhtar H (2010) Disruption of androgen and estrogen receptor activity in prostate cancer by a novel dietary diterpene carnosol: implications for chemoprevention. Cancer Prev Res (Phila) 3(9):1112-1123
29. Kjeldsen LS, Bonefeld-Jørgensen EC (2013) Perfluorinated compounds affect the function of sex hormone receptors. Environ Sci Pollut Res Int 20(11):8031-8044
30. Byrne C, Divekar SD, Storchan GB, Parodi DA, Martin MB (2013) Metals and breast cancer. J Mammary Gland Biol Neoplasia 18(1):63-73
31. Orrego R, Guchardi J, Krause R, Holdway D (2010) Estrogenic and anti-estrogenic effects of wood extractives present in pulp and paper mill effluents on rainbow trout. Aquat Toxicol 99(2):160-167
32. Zhang X, Mukerji R, Samadi AK, Cohen MS (2011) Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells. BMC Complement Altern Med 11:84
33. Shi C, Na N, Zhu X, Xu J (2013) Estrogenic effect of ginsenoside Rg1 on APP processing in post-menopausal platelets. Platelets 24(1):51-62
34. Chen D, Carter TH, Auborn KJ (2004) Apoptosis in cervical cancer cells: implications for adjunct anti-estrogen therapy for cervical cancer. Anticancer Res 24(5A):2649-2656
35. Martínez-Campa CM, Alonso-González C, Mediavilla MD, Cos S, González A, Sanchez-Barcelo EJ (2008) Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells. Cancer Lett 268(2):272-277
36. Chen CC, Shieh B, Jin YT, Liau YE, Huang CH, Liou JT, Wu LW, Huang W, Young KC, Lai MD, Liu HS, Li C (2001) Microarray profiling of gene expression patterns in bladder tumor cells treated with genistein. J Biomed Sci 8(2):214-222
37. Watanabe H, Suzuki A, Mizutani T, Khono S, Lubahn DB, Handa H, Iguchi T (2002) Genome-wide analysis of changes in early gene expression induced by oestrogen. Genes Cells 7(5):497-507
38. Naciff JM, Jump ML, Torontali SM, Carr GJ, Tiesman JP, Overmann GJ, Daston GP (2002) Gene expression profile induced by 17alpha-ethynyl estradiol, bisphenol A, and genistein in the developing female reproductive system of the rat. Toxicol Sci 68(1):184-199
39. Levenson AS, Kliakhandler IL, Svoboda KM, Pease KM, Kaiser SA, Ward JE 3rd, Jordan VC (2002) Molecular classification of selective oestrogen receptor modulators on the basis of gene expression profiles of breast cancer cells expressing oestrogen receptor alpha. Br J Cancer 87(4):449-456
40. Adachi T, Komiyama M, Ono Y, Koh KB, Sakurai K, Shibayama T, Kato M, Yoshikawa T, Seki N, Iguchi T, Mori C (2002) Toxicogenomic effects of neonatal exposure to diethylstilbestrol on mouse testicular gene expression in the long term: a study using cDNA microarray analysis. Mol Reprod Dev 63(1):17-23
41. Tabuchi Y, Zhao QL, Kondo T (2002) DNA microarray analysis of differentially expressed genes responsive to bisphenol A, an alkylphenol derivative, in an in vitro mouse Sertoli cell model. Jpn J Pharmacol 89(4):413-416
42. Inoue A, Yoshida N, Omoto Y, Oguchi S, Yamori T, Kiyama R, Hayashi S (2002) Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol 29(2):175-192
43. Li Y, Sarkar FH (2002) Gene expression profiles of genistein-treated PC3 prostate cancer cells. J Nutr 132(12):3623-3631
44. Terasaka S, Aita Y, Inoue A, Hayashi S, Nishigaki M, Aoyagi K, Sasaki H, Wada-Kiyama Y, Sakuma Y, Akaba S, Tanaka J, Sone H, Yonemoto J, Tanji M, Kiyama R (2004) Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. Environ Health Perspect 112(7):773-781
45. Dong S, Furutani Y, Suto Y, Furutani M, Zhu Y, Yoneyama M, Kato T, Itabe H, Nishikawa T, Tomimatsu H, Tanaka T, Kasanuki H, Masaki T, Kiyama R, Matsuoka R (2012) Estrogen-like activity and dual roles in cell signaling of an Agaricus blazei Murrill mycelia-dikaryon extract. Microbiol Res 167(4):231-237
46. Zhu Y, Ogaeri T, Suzuki J, Dong S, Aoyagi T, Mizuki K, Takasugi M, Isobe S, Kiyama R (2011) Application of Fluolid-Orange-labeled probes for DNA microarray and immunological assays. Biotechnol Lett 33(9):1759-1766
47. Brown AM, Jeltsch JM, Roberts M, Chambon P (1984) Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci USA 81(20):6344-6348
48. Ghosh MG, Thompson DA, Weigel RJ (2000) PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res 60(22):6367-6375
49. Qin C, Singh P, Safe S (1999) Transcriptional activation of insulin-like growth factor-binding protein-4 by 17beta-estradiol in MCF-7 cells: role of estrogen receptor-Sp1 complexes. Endocrinology 140(6):2501-2508
50. Inoue A, Omoto Y, Yamaguchi Y, Kiyama R, Hayashi SI (2004) Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells. J Mol Endocrinol 32(3):649-661
51. Rho JY, Wada-Kiyama Y, Onishi Y, Kiyama R, Sakuma Y (2004) Expressional regulation of neuronal and cancer-related genes by estrogen in adult female rats. Endocr Res 30(2):257-267
52. Ise R, Han D, Takahashi Y, Terasaka S, Inoue A, Tanji M, Kiyama R (2005) Expression profiling of the estrogen responsive genes in response to phytoestrogens using a customized DNA microarray. FEBS Lett 579(7):1732-1740
53. Terasaka S, Inoue A, Tanji M, Kiyama R (2006) Expression profiling of estrogen-responsive genes in breast cancer cells treated with alkylphenols, chlorinated phenols, parabens, or bis- and benzoylphenols for evaluation of estrogenic activity. Toxicol Lett 163(2):130-141
54. Dong S, Furutani Y, Kimura S, Zhu Y, Kawabata K, Furutani M, Nishikawa T, Tanaka T, Masaki T, Matsuoka R, Kiyama R (2013) Brefeldin A is an estrogenic, Erk1/2-activating component in the extract of Agaricus blazei mycelia. J Agric Food Chem 61(1):128-136
55. Zhu Y, Kitamura K, Maruyama A, Higashihara T, Kiyama R (2012) Estrogenic activity of bio-degradation products of C-heavy oil revealed by gene-expression profiling using an oligo-DNA microarray system. Environ Pollut 168:10-14
56. Parveen M, Zhu Y, Kiyama R (2009) Expression profiling of the genes responding to zearalenone and its analogues using estrogen-responsive genes. FEBS Lett 583(14):2377-2384
57. Inoue A, Seino Y, Terasaka S, Hayashi S, Yamori T, Tanji M, Kiyama R (2007) Comparative profiling of the gene expression for estrogen responsiveness in cultured human cell lines. Toxicol In Vitro 21(4):741-752
58. Parveen M, Inoue A, Ise R, Tanji M, Kiyama R (2008) Evaluation of estrogenic activity of phthalate esters by gene expression profiling using a focused microarray (EstrArray). Environ Toxicol Chem 27(6):1416-1425
59. Dong S, Inoue A, Zhu Y, Tanji M, Kiyama R (2007) Activation of rapid signaling pathways and the subsequent transcriptional regulation for the proliferation of breast cancer MCF-7 cells by the treatment with an extract of Glycyrrhiza glabra root. Food Chem Toxicol 45(12):2470-2478
60. Dong S, Kiyama R (2009) Characterisation of oestrogenic activity of ginsenosides in MCF-7 cells using a customised DNA microarray. Food Chem 113(2):672-678
61. Klebanov L, Qiu X, Welle S, Yakovlev A (2007) Statistical methods and microarray data. Nat Biotechnol 25(1):25-26
62. Michiels S, Koscielny S, Hill C (2005) Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 365(9458):488-492
63. Ioannidis JP (2005) Microarrays and molecular research: noise discovery? Lancet 365(9458):454-455
64. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P (2007) Molecular Biology of the Cell, 5th edn. Garland Science, New York
65. Filardo EJ, Thomas P (2005) GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 16(8):362-367
66. Fu XD, Simoncini T (2008) Extra-nuclear signaling of estrogen receptors. IUBMB Life 60(8):502-510
67. Nilsson S, Mäkelä S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA (2001) Mechanisms of estrogen action. Physiol Rev 81(4):1535-1565
68. Green S, Chambon P (1988) Nuclear receptors enhance our understanding of transcription regulation. Trends Genet 4(11):309-314
69. Abot A, Fontaine C, Raymond-Letron I, Flouriot G, Adlanmerini M, Buscato M, Otto C, Bergès H, Laurell H, Gourdy P, Lenfant F, Arnal JF (2013) The AF-1 activation function of estrogen receptor α is necessary and sufficient for uterine epithelial cell proliferation in vivo. Endocrinology 154(6):2222-2233
70. Billon-Galés A, Krust A, Fontaine C, Abot A, Flouriot G, Toutain C, Berges H, Gadeau AP, Lenfant F, Gourdy P, Chambon P, Arnal JF (2011) Activation function 2 (AF2) of estrogen receptor-alpha is required for the atheroprotective action of estradiol but not to accelerate endothelial healing. Proc Natl Acad Sci USA 108(32):13311-13316
71. Feng W, Webb P, Nguyen P, Liu X, Li J, Karin M, Kushner PJ (2001) Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway. Mol Endocrinol 15(1):32-45
72. Cheskis BJ, Greger J, Cooch N, McNally C, Mclarney S, Lam HS, Rutledge S, Mekonnen B, Hauze D, Nagpal S, Freedman LP (2008) MNAR plays an important role in ERa activation of Src/MAPK and PI3 K/Akt signaling pathways. Steroids 73(9-10):901-905
73. Makker A, Goel MM, Das V, Agarwal A (2012) PI3 K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update. Gynecol Endocrinol 28(3):175-181
74. Eisinger-Mathason TS, Andrade J, Lannigan DA (2010) RSK in tumorigenesis: connections to steroid signaling. Steroids 75(3):191-202
75. Wertheimer E, Gutierrez-Uzquiza A, Rosemblit C, Lopez-Haber C, Sosa MS, Kazanietz MG (2012) Rac signaling in breast cancer: a tale of GEFs and GAPs. Cell Signal 24(2):353-362
76. Sonderegger S, Pollheimer J, Knöfler M (2010) Wnt signalling in implantation, decidualisation and placental differentiation - review. Placenta 31(10):839-847
77. Butt AJ, McNeil CM, Musgrove EA, Sutherland RL (2005) Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E. Endocr Relat Cancer 12(Suppl 1):S47-S59
78. Levin ER (2005) Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 19(8):1951-1959
79. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb P (2000) Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74(5):311-317
80. Strobl JS, Wonderlin WF, Flynn DC (1995) Mitogenic signal transduction in human breast cancer cells. Gen Pharmacol 26(8):1643-1649
81. Vivacqua A, Lappano R, De Marco P, Sisci D, Aquila S, De Amicis F, Fuqua SA, Andò S, Maggiolini M (2009) G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells. Mol Endocrinol 23(11):1815-1826
82. Holm A, Baldetorp B, Olde B, Leeb-Lundberg LM, Nilsson BO (2011) The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle. J Vasc Res 48(4):327-335
83. Nilsson BO, Olde B, Leeb-Lundberg LM (2011) G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: a new player in cardiovascular and metabolic oestrogenic signalling. Br J Pharmacol 163(6):1131-1139
84. Werner H, Bruchim I (2012) IGF-1 and BRCA1 signalling pathways in familial cancer. Lancet Oncol 13(12):e537-e544
85. Dong S, Terasaka S, Kiyama R (2011) Bisphenol A induces a rapid activation of Erk1/2 through GPR30 in human breast cancer cells. Environ Pollut 159(1):212-218
86. Mense SM, Hei TK, Ganju RK, Bhat HK (2008) Phytoestrogens and breast cancer prevention: possible mechanisms of action. Environ Health Perspect 116(4):426-433
87. Adlercreutz H (1995) Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 103(Suppl 7):103-112
88. Oseni T, Patel R, Pyle J, Jordan VC (2008) Selective estrogen receptor modulators and phytoestrogens. Planta Med 74(13):1656-1665
89. Patisaul HB, Jefferson W (2010) The pros and cons of phytoestrogens. Front Neuroendocrinol 31(4):400-419
90. Zand RS, Jenkins DJ, Diamandis EP (2000) Steroid hormone activity of flavonoids and related compounds. Breast Cancer Res Treat 62(1):35-49
91. Mueller SO (2002) Overview of in vitro tools to assess the estrogenic and antiestrogenic activity of phytoestrogens. J Chromatogr B Analyt Technol Biomed Life Sci 777(1-2):155-165
92. Hammond GL (2011) Diverse roles for sex hormone-binding globulin in reproduction. Biol Reprod 85(3):431-441
93. Zeghouf M, Guibert B, Zeeh JC, Cherfils J (2005) Arf, Sec7 and Brefeldin A: a model towards the therapeutic inhibition of guanine nucleotide-exchange factors. Biochem Soc Trans 33(Pt 6):1265-1268
94. Palayoor ST, J-Aryankalayil M, Makinde AY, Cerna D, Falduto MT, Magnuson SR, Coleman CN (2012) Gene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effects. J Cardiovasc Pharmacol 59(6):487-499
95. Lara-Pezzi E, Terracciano CM, Soppa GK, Smolenski RT, Felkin LE, Yacoub MH, Barton PJ (2009) A gene expression profile of the myocardial response to clenbuterol. J Cardiovasc Transl Res 2(2):191-197
96. Le Fevre AC, Boitier E, Marchandeau JP, Sarasin A, Thybaud V (2007) Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profiling. Mutat Res 619(1-2):16-29
97. Van Hummelen P, Sasaki J (2010) State-of-the-art genomics approaches in toxicology. Mutat Res 705(3):165-171
98. Stierum R, Burgemeister R, van Helvoort A, Peijnenburg A, Schütze K, Seidelin M, Vang O, van Ommen B (2001) Functional food ingredients against colorectal cancer. An example project integrating functional genomics, nutrition and health. Nutr Metab Cardiovasc Dis 11(4 Suppl):94-98
99. van Dijk JP, Leifert C, Barros E, Kok EJ (2010) Gene expression profiling for food safety assessment: examples in potato and maize. Regul Toxicol Pharmacol 58(3 Suppl):S21-S25
100. Rasooly A, Herold KE (2008) Food microbial pathogen detection and analysis using DNA microarray technologies. Foodborne Pathog Dis 5(4):531-550
101. Kuiper HA, Kok EJ, Engel KH (2003) Exploitation of molecular profiling techniques for GM food safety assessment. Curr Opin Biotechnol 14(2):238-243
102. Fan X, Shi L, Fang H, Cheng Y, Perkins R, Tong W (2010) DNA microarrays are predictive of cancer prognosis: a re-evaluation. Clin Cancer Res 16(2):629-636
103. Lühe A, Suter L, Ruepp S, Singer T, Weiser T, Albertini S (2005) Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit? Mutat Res 575(1-2):102-115
104. Lord PG, Nie A (2006) McMillian M. Application of genomics in preclinical drug safety evaluation. Basic Clin Pharmacol Toxicol 98(6):537-546
105. Pennie W, Pettit SD, Lord PG (2004) Toxicogenomics in risk assessment: an overview of an HESI collaborative research program. Environ Health Perspect 112(4):417-419
106. Currie RA (2012) Toxicogenomics: the challenges and opportunities to identify biomarkers, signatures and thresholds to support mode-of-action. Mutat Res 746(2):97-103
107. Fent K, Sumpter JP (2011) Progress and promises in toxicogenomics in aquatic toxicology: is technical innovation driving scientific innovation? Aquat Toxicol 105(3-4 Suppl):25-39
108. Fan JB, Hu SX, Craumer WC, Barker DL (2005) BeadArray-based solutions for enabling the promise of pharmacogenomics. Biotechniques 39(4):583-588
109. Cahan P, Rovegno F, Mooney D, Newman JC, St Laurent G 3rd, McCaffrey TA (2007) Meta-analysis of microarray results: challenges, opportunities, and recommendations for standardization. Gene 401(1-2):12-18
110. Ross JS, Hatzis C, Symmans WF, Pusztai L, Hortobágyi GN (2008) Commercialized multigene predictors of clinical outcome for breast cancer. Oncologist 13(5):477-493
111. Marquardt JU, Galle PR, Teufel A (2012) Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies. J Hepatol 56(1):267-275
112. Fu J, Jeffrey SS (2007) Transcriptomic signatures in breast cancer. Mol BioSyst 3(7):466-472
113. Reamon-Buettner SM, Mutschler V, Borlak J (2008) The next innovation cycle in toxicogenomics: environmental epigenetics. Mutat Res 659(1-2):158-165
114. Hudson J, Khazragui HF (2013) Into the valley of death: research to innovation. Drug Discov Today 18(13-14):610-613
115. Lenoir T, Giannella E (2006) The emergence and diffusion of DNA microarray technology. J Biomed Discov Collab 1:11
116. Lequin RM (2005) Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA). Clin Chem 51(12):2415-2418
117. (2006) Making the most of microarrays (Editorial). Nat Biotechnol 24(9):1039
118. MAQC Consortium (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24(9):1151-1161
119. MAQC Consortium (2010) The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol 28(8):827-838
120. SPIDIA, EU. (2013) SPIDIA Newsletter, 03/2013
121. Pazzagli M, Malentacchi F, Simi L, Orlando C, Wyrich R, Günther K, Hartmann CC, Verderio P, Pizzamiglio S, Ciniselli CM, Tichopad A, Kubista M, Gelmini S (2013) SPIDIA-RNA: first external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. Methods 59(1):20-31
122. Watanabe H, Suzuki A, Goto M, Lubahn DB, Handa H, Iguchi T (2004) Tissue-specific estrogenic and non-estrogenic effects of a xenoestrogen, nonylphenol. J Mol Endocrinol 33(1):243-252
123. Koda T, Umezu T, Kamata R, Morohoshi K, Ohta T, Morita M (2005) Uterotrophic effects of benzophenone derivatives and a p-hydroxybenzoate used in ultraviolet screens. Environ Res 98(1):40-45
124. Routledge EJ, Parker J, Odum J, Ashby J, Sumpter JP (1998) Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol Appl Pharmacol 153(1):12-19
125. Odum J, Pyrah IT, Foster JR, Van Miller JP, Joiner RL, Ashby J (1999) Comparative activities of p-nonylphenol and diethylstilbestrol in noble rat mammary gland and uterotrophic assays. Regul Toxicol Pharmacol 29(2 Pt 1):184-195
126. Hilf R, Lerner LJ, Lang E, Borman A (1963) The effect of progressive sarcoma 180 growth upon the uterotrophic response to estrogen in mice. Cancer Res 23:304-309
127. Ashby J, Tinwell H, Pennie W, Brooks AN, Lefevre PA, Beresford N, Sumpter JP (1999) Partial and weak oestrogenicity of the red wine constituent resveratrol: consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects. J Appl Toxicol 19(1):39-45
128. Saggar JK, Chen J, Corey P, Thompson LU (2010) The effect of secoisolariciresinol diglucoside and flaxseed oil, alone and in combination, on MCF-7 tumor growth and signaling pathways. Nutr Cancer 62(4):533-542
129. Bulger WH, Muccitelli RM, Kupfer D (1978) Interactions of methoxychlor, methoxychlor base-soluble contaminant, and 2,2-bis(p-hydroxyphenyl)-1,1,1- trichloroethane with rat uterine estrogen receptor. J Toxicol Environ Health 4(5-6):881-893
130. Laws SC, Carey SA, Ferrell JM, Bodman GJ, Cooper RL (2000) Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicol Sci 54(1):154-167
131. Hutz RJ, Carvan MJ, Baldridge MG, Conley LK, Heiden TK (2006) Environmental toxicants and effects on female reproductive function. Tren Reprod Bio 2:1-11
132. Salama J, Chakraborty TR, Ng L, Gore AC (2003) Effects of polychlorinated biphenyls on estrogen receptor-beta expression in the anteroventral periventricular nucleus. Environ Health Perspect 111(10):1278-1282
133. Zacharewski TR, Meek MD, Clemons JH, Wu ZF, Fielden MR, Matthews JB (1998) Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters. Toxicol Sci 46(2):282-293
134. Carthew P, Edwards RE, Nolan BM (1999) Uterotrophic effects of tamoxifen, toremifene, and raloxifene do not predict endometrial cell proliferation in the ovariectomized CD1 mouse. Toxicol Appl Pharmacol 158(1):24-32
135. Davey JC, Bodwell JE, Gosse JA, Hamilton JW (2007) Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture. Toxicol Sci 98(1):75-86
136. Garcia-Morales P, Saceda M, Kenney N, Kim N, Salomon DS, Gottardis MM, Solomon HB, Sholler PF, Jordan VC, Martin MB (1994) Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J Biol Chem 269(24):16896-16901
137. Chang MX, Wang YP, Nie P (2009) Zebrafish peptidoglycan recognition protein SC (zfPGRP-SC) mediates multiple intracellular signaling pathways. Fish Shellfish Immunol 26(2):264-274
138. Mendes Sdos S, Candi A, Vansteenbrugge M, Pignon MR, Bult H, Boudjeltia KZ, Munaut C, Raes M (2009) Microarray analyses of the effects of NF-kappaB or PI3 K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells: synergistic effects of rapamycin on LPS-induced MMP9-overexpression. Cell Signal 21(7):1109-1122
139. Cízková A, Stránecký V, Ivánek R, Hartmannová H, Nosková L, Piherová L, Tesarová M, Hansíková H, Honzík T, Zeman J, Divina P, Potocká A, Paul J, Sperl W, Mayr JA, Seneca S, Houstk J, Kmoch S (2008) Development of a human mitochondrial oligonucleotide microarray (h-MitoArray) and gene expression analysis of fibroblast cell lines from 13 patients with isolated F1Fo ATP synthase deficiency. BMC Genom 9:38
140. Copple BL, Bai S, Burgoon LD, Moon JO (2011) Hypoxia-inducible factor-1α regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis. Liver Int 31(2):230-244
141. Lee YJ, Ko EH, Kim JE, Kim E, Lee H, Choi H, Yu JH, Kim HJ, Seong JK, Kim KS, Kim JW (2012) Nuclear receptor PPARγ-regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis. Proc Natl Acad Sci USA 109(34):13656-13661
142. Nakaoka Y, Nishida K, Narimatsu M, Kamiya A, Minami T, Sawa H, Okawa K, Fujio Y, Koyama T, Maeda M, Sone M, Yamasaki S, Arai Y, Koh GY, Kodama T, Hirota H, Otsu K, Hirano T, Mochizuki N (2007) Gab family proteins are essential for postnatal maintenance of cardiac function via neuregulin-1/ErbB signaling. J Clin Invest 117(7):1771-1781
143. Granese B, Scala I, Spatuzza C, Valentino A, Coletta M, Vacca RA, De Luca P, Andria G (2013) Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome. BMC Med Genomics 6(1):24
144. Reichmann J, Crichton JH, Madej MJ, Taggart M, Gautier P, Garcia-Perez JL, Meehan RR, Adams IR (2012) Microarray analysis of LTR retrotransposon silencing identifies Hdac1 as a regulator of retrotransposon expression in mouse embryonic stem cells. PLoS Comput Biol 8(4):e1002486
145. Lee DH, Li Y, Shin DH, Yi SA, Bang SY, Park EK, Han JW, Kwon SH (2013) DNA microarray profiling of genes differentially regulated by three heterochromatin protein 1 (HP1) homologs in Drosophila. Biochem Biophys Res Commun 434(4):820-828
146. Khamas A, Ishikawa T, Shimokawa K, Mogushi K, Iida S, Ishiguro M, Mizushima H, Tanaka H, Uetake H, Sugihara K (2012) Screening for epigenetically masked genes in colorectal cancer Using 5-Aza-2′-deoxycytidine, microarray and gene expression profile. Cancer Genomics Proteomics 9(2):67-75
147. Faherty CS, Merrell DS, Semino-Mora C, Dubois A, Ramaswamy AV, Maurelli AT (2010) Microarray analysis of Shigella flexneri-infected epithelial cells identifies host factors important for apoptosis inhibition. BMC Genom 11:272
148. Nasirudeen AM, Liu DX (2009) Gene expression profiling by microarray analysis reveals an important role for caspase-1 in dengue virus-induced p53-mediated apoptosis. J Med Virol 81(6):1069-1081
149. Wang SH, Van Antwerp M, Kuick R, Gauger PG, Doherty GM, Fan YY, Baker JR Jr (2007) Microarray analysis of cytokine activation of apoptosis pathways in the thyroid. Endocrinology 148(10):4844-4852
150. Burgess ST, Downing A, Watkins CA, Marr EJ, Nisbet AJ, Kenyon F, McNair C, Huntley JF (2012) Development of a cDNA microarray for the measurement of gene expression in the sheep scab mite Psoroptes ovis. Parasit Vectors 5:30
151. van der Vos KE, Eliasson P, Proikas-Cezanne T, Vervoort SJ, van Boxtel R, Putker M, van Zutphen IJ, Mauthe M, Zellmer S, Pals C, Verhagen LP, Groot Koerkamp MJ, Braat AK, Dansen TB, Holstege FC, Gebhardt R, Burgering BM, Coffer PJ (2012) Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy. Nat Cell Biol 14(8):829-837
152. Bolukbasi E, Vass S, Cobbe N, Nelson B, Simossis V, Dunbar DR, Heck MM (2012) Drosophila poly suggests a novel role for the Elongator complex in insulin receptor-target of rapamycin signalling. Open Biol 2(1):110031
153. Solskov L, Magnusson NE, Kristiansen SB, Jessen N, Nielsen TT, Schmitz O, Bøtker HE, Lund S (2012) Microarray expression analysis in delayed cardioprotection: the effect of exercise, AICAR, or metformin and the possible role of AMP-activated protein kinase (AMPK). Mol Cell Biochem 360(1-2):353-362
154. Saikia M, Krokowski D, Guan BJ, Ivanov P, Parisien M, Hu GF, Anderson P, Pan T, Hatzoglou M (2012) Genome-wide identification and quantitative analysis of cleaved tRNA fragments induced by cellular stress. J Biol Chem 287(51):42708-42725
155. Villas-Bôas CS, Conceição TM, Ramírez J, Santoro AB, Da Poian AT, Montero-Lomelí M (2009) Dengue virus-induced regulation of the host cell translational machinery. Braz J Med Biol Res 42(11):1020-1026
156. Grzmil M, Morin P Jr, Lino MM, Merlo A, Frank S, Wang Y, Moncayo G, Hemmings BA (2011) MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma. Cancer Res 71(6):2392-2402
157. Stockwell SR, Platt G, Barrie SE, Zoumpoulidou G, Te Poele RH, Aherne GW, Wilson SC, Sheldrake P, McDonald E, Venet M, Soudy C, Elustondo F, Rigoreau L, Blagg J, Workman P, Garrett MD, Mittnacht S (2012) Mechanism-based screen for G1/S checkpoint activators identifies a selective activator of EIF2AK3/PERK signalling. PLoS One 7(1):e28568
158. Eguchi T, Takaki T, Itadani H, Kotani H (2007) RB silencing compromises the DNA damage-induced G2/M checkpoint and causes deregulated expression of the ECT2 oncogene. Oncogene 26(4):509-520
159. Wada-Kiyama Y, Suzuki C, Hamada T, Rai D, Kiyama R, Kaneda M, Sakuma Y (2013) Estrogen-induced cell signaling in the sexually dimorphic nucleus of the rat preoptic area: potential involvement of cofilin in actin dynamics for cell migration. Biochem Biophys Res Commun 434(2):287-292
160. Simon-Areces J, Dopazo A, Dettenhofer M, Rodriguez-Tebar A, Garcia-Segura LM, Arevalo MA (2011) Formin1 mediates the induction of dendritogenesis and synaptogenesis by neurogenin3 in mouse hippocampal neurons. PLoS One 6(7):e21825
161. Caramori ML, Kim Y, Moore JH, Rich SS, Mychaleckyj JC, Kikyo N, Mauer M (2012) Gene expression differences in skin fibroblasts in identical twins discordant for type 1 diabetes. Diabetes 61(3):739-744
162. Kutty RK, Nagineni CN, Samuel W, Vijayasarathy C, Hooks JJ, Redmond TM (2010) Inflammatory cytokines regulate microRNA-155 expression in human retinal pigment epithelial cells by activating JAK/STAT pathway. Biochem Biophys Res Commun 402(2):390-395
163. Abend JR, Ramalingam D, Kieffer-Kwon P, Uldrick TS, Yarchoan R, Ziegelbauer JM (2012) Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression. J Virol 86(21):11663-11674
164. Chang TT, Walther I, Li CF, Boonyaratanakornkit J, Galleri G, Meloni MA, Pippia P, Cogoli A, Hughes-Fulford M (2012) The Rel/NF-κB pathway and transcription of immediate early genes in T cell activation are inhibited by microgravity. J Leukoc Biol 92(6):1133-1145
165. Yang Y, Sun H, Mo X, Liu Y, Jia H, Li X, Zhang G, Li Q (2012) Prediction of novel genes associated with negative regulators of toll-like receptors-induced inflammation based on endotoxin tolerance. Inflammation 35(6):1889-1899
166. Franke A, Niederfellner GJ, Klein C, Burtscher H (2011) Antibodies against CD20 or B-cell receptor induce similar transcription patterns in human lymphoma cell lines. PLoS One 6(2):e16596
167. Kim JY, Lim MK, Sheen DH, Kim C, Lee SY, Park H, Lee MJ, Lee SK, Yang YS, Shim SC (2011) Gene Expression Profile of T-cell Receptors in the Synovium, Peripheral Blood, and Thymus during the Initial Phase of Collagen-induced Arthritis. Immune Netw 11(5):258-267
168. Walker PR, Smith B, Liu QY, Famili AF, Valdés JJ, Liu Z, Lach B (2004) Data mining of gene expression changes in Alzheimer brain. Artif Intell Med 31(2):137-154
169. Dumitriu A, Latourelle JC, Hadzi TC, Pankratz N, Garza D, Miller JP, Vance JM, Foroud T, Beach TG, Myers RH (2012) Gene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation. PLoS Genet 8(6):e1002794
170. Nguyen HP, Sprung CN, Gargett CE (2012) Differential expression of Wnt signaling molecules between pre- and postmenopausal endometrial epithelial cells suggests a population of putative epithelial stem/progenitor cells reside in the basalis layer. Endocrinology 153(6):2870-2883
171. Viatour P, Ehmer U, Saddic LA, Dorrell C, Andersen JB, Lin C, Zmoos AF, Mazur PK, Schaffer BE, Ostermeier A, Vogel H, Sylvester KG, Thorgeirsson SS, Grompe M, Sage J (2011) Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway. J Exp Med 208(10):1963-1976
172. Nfonsam LE, Cano C, Mudge J, Schilkey FD, Curtiss J (2012) Analysis of the transcriptomes downstream of Eyeless and the Hedgehog, Decapentaplegic and Notch signaling pathways in Drosophila melanogaster. PLoS One 7(8):e44583
173. Choi SI, Yoo YM, Kim BY, Kim TI, Cho HJ, Ahn SY, Lee HK, Cho HS, Kim EK (2010) Involvement of TGF-β receptor- and integrin-mediated signaling pathways in the pathogenesis of granular corneal dystrophy II. Invest Ophthalmol Vis Sci 51(4):1832-1847